Independent health informationUrgent helpHow information is checked
Evidence Health
Menu
Search
Condition

Male Infertility and Sperm Health: Causes, Tests and Next Steps

Male-factor infertility can involve sperm production, transport, ejaculation, sexual function, hormones, genetics, or several factors at once. A semen analysis is the core laboratory test, but it is a snapshot with natural variation—not a verdict that someone is fertile or infertile. Useful care combines the result with history, examination, the reproductive goal, and parallel assessment of the other partner when applicable.

Written byEvidence Health Editorial Team
Evidence checked2026-08-21
References6 sources
UpdatedAugust 24, 2026
A healthcare professional discussing fertility care with an adult patient
On this page

Male-factor infertility can involve sperm production, transport, ejaculation, sexual function, hormones, genetics, or several factors at once. A semen analysis is the core laboratory test, but it is a snapshot with natural variation—not a verdict that someone is fertile or infertile. Useful care combines the result with history, examination, the reproductive goal, and parallel assessment of the other partner when applicable.

Key points

  • Evaluate relevant partners at the same time; waiting for one person’s work-up to finish can delay care.
  • A standard semen analysis measures volume and sperm number, movement, and shape under controlled laboratory conditions.
  • Values below a WHO reference percentile are not a boundary between fertility and infertility, and one abnormal sample often needs confirmation.
  • External testosterone and anabolic steroids can strongly suppress sperm production, even when marketed as performance or hormone support.
  • Hormone, genetic, ultrasound, infection, and sperm DNA tests are selected from the history and semen pattern rather than ordered for everyone.

How a male factor can affect conception

Testes must produce sperm, hormones from the brain and testes must support that process, and ducts must transport sperm into semen. Erection and ejaculation must allow sperm to reach the reproductive tract or be collected for treatment. Sperm then need enough movement and functional capacity to reach and fertilize an egg.

A problem can occur before the testes, within them, or after sperm are produced. Hormonal signaling disorders are sometimes called pre-testicular causes. Testicular causes include genetic conditions, prior damage, cancer treatment, infection, or impaired production. Post-testicular causes include blockage, absent ducts, retrograde ejaculation, and other transport or delivery problems.

Infertility is a shared clinical situation rather than a measure of masculinity or sexual ability. A person can have normal erections and low sperm production, or erectile difficulty with normal semen. Fertility and sexual performance are related only in selected ways.

When to begin an assessment

General timing depends on the age and history of the person providing eggs, how long pregnancy has been attempted, and local guidance. Assessment should begin earlier with a history of undescended testes, testicular torsion or trauma, pelvic or groin surgery, chemotherapy or radiation, genetic disease, prior infertility, erectile or ejaculation difficulty, or a known abnormal semen result.

Do not wait through a standard time threshold if there is a testicular lump, persistent swelling, marked size change, absent testis, or significant pain. Fertility preservation should be discussed before treatment likely to damage sperm production whenever time allows.

The complete pathway is explained in Infertility: Causes, Tests and When to Seek Help.

What the history covers

A clinician asks about previous pregnancies, duration of attempts, childhood testicular development, puberty, operations, infections, injuries, cancer treatment, chronic disease, fever, sexual function, and family history. Medicines, testosterone, anabolic steroids, supplements, recreational drugs, smoking, alcohol, heat and workplace exposures all matter.

Timing helps. Sperm development takes weeks and the semen sample reflects health and exposures over preceding months, not only the day of collection. A recent high fever or acute illness can temporarily alter a result. This does not mean every abnormal value should be attributed to stress or heat without evaluation.

Ask about erection, orgasm, semen volume, painful or dry ejaculation, blood in semen, urinary symptoms, and whether semen appears in urine after orgasm. These details can identify a delivery or obstruction problem that a sperm count alone cannot explain.

Physical examination is part of the work-up

Examination can assess testicular position, size and consistency, the epididymis and sperm ducts, a varicocele, penile anatomy, body-hair pattern, and breast tissue. A testicular mass requires prompt investigation because fertility problems can occasionally be associated with important wider health conditions.

A varicocele is an enlargement of veins around a testis, commonly more noticeable while standing or straining. Many people with a varicocele are fertile. Treatment is considered from the clinical examination, semen pattern, symptoms, reproductive timeline, and the other partner’s fertility—not from a scan finding alone.

Sudden scrotal pain

Sudden severe testicular or scrotal pain, especially with nausea, swelling, or a high-riding testis, is an emergency because torsion can cut off blood flow. Do not wait for a fertility appointment or try to confirm the cause at home.

How a semen sample is collected

The laboratory provides a specified period without ejaculation, a sterile container, and instructions for collection and transport. Follow that laboratory’s directions because timing, temperature, delay, loss of part of the sample, lubricant, or the wrong container can affect interpretation. Report any collection problem rather than trying to hide it.

Collection by masturbation in a private room is common, but approved collection condoms or home collection may be available in some services. Ordinary condoms and many lubricants can harm sperm or contaminate testing. Cultural, religious, disability, and sexual concerns should be discussed so the service can offer an acceptable method.

If no sperm are seen, the laboratory may examine a concentrated sample and the clinician may repeat the test before diagnosing azoospermia. A lab report should use standardized methods and quality control consistent with the WHO semen manual.

What the semen report measures

Volume is the amount of semen collected. Low volume can reflect incomplete collection, short interval, retrograde ejaculation, blockage, gland dysfunction, or hormonal factors. High or low volume alone does not determine fertility.

Concentration is the number of sperm per unit of semen, while total sperm number combines concentration with volume. The total count can be more informative than concentration in isolation.

Motility describes movement, including progressive movement through the sample. Morphology describes the proportion meeting strict shape criteria. Strict morphology often yields a low-looking percentage even in reference populations; it must not be interpreted as a percentage of “normal babies” or functional certainty.

Other reported measures can include liquefaction, viscosity, pH, vitality when many sperm are immotile, and white blood cells when indicated. None substitutes for the whole clinical picture.

Reference values are not pass or fail marks

WHO reference distributions are based on men whose partners conceived within a defined period. The lower reference percentile does not divide fertile from infertile people. Pregnancy can occur with a result below a threshold, and a result above it cannot guarantee conception.

Parameters also interact. A lower concentration with strong progressive motility has a different context from several severely reduced measures. Age and fertility of the egg source, timing, tubal factors, duration of attempts, and previous pregnancy matter.

Because semen varies, current European guidance recommends at least two consecutive analyses when the baseline result is abnormal. The appropriate interval depends on the finding, recent illness, and clinical urgency. Do not repeat samples weekly in search of a preferred number unless the specialist requests it.

What can cause an abnormal result

Genetic and chromosomal conditions, undescended testes, torsion, trauma, cancer, chemotherapy, radiation, severe infection, obstruction, varicocele, hormone disorders, chronic systemic disease, and some medicines can affect sperm. In many cases, no single cause is identified after appropriate evaluation; this is called idiopathic male infertility.

External testosterone and anabolic steroids suppress brain signals that stimulate the testes. Blood testosterone may look high while sperm production falls markedly or stops. Recovery after discontinuation varies and must be supervised, particularly when hormones were prescribed for a medical or gender-affirming indication.

Smoking, heavy alcohol use, recreational drugs, severe heat exposure, undernutrition, sleep problems, and some occupational toxins may contribute. These are risk factors, not proof of blame, and their effect size differs. A plan should focus on realistic health changes while diagnostic care continues.

Hormone and genetic testing

Hormone tests can include gonadotropins and testosterone when sperm counts are repeatedly reduced, sexual or physical features suggest endocrine disease, or azoospermia is present. The pattern helps distinguish low stimulation from primary testicular impairment. One unscheduled result is not enough to start hormone treatment.

Genetic testing may be recommended for azoospermia, very low sperm concentration, absent sperm ducts, characteristic examination findings, recurrent pregnancy loss, or family history. Testing can affect the person’s health, relatives, and the chance of passing a condition to children, so genetic counseling is important.

Imaging is targeted. Scrotal ultrasound can assess a mass or unclear examination. Transrectal imaging may be used when ejaculatory-duct obstruction is suspected. Routine ultrasound for every person with an abnormal sample is not necessarily useful.

Sperm DNA fragmentation and advanced tests

Standard semen analysis cannot measure every aspect of sperm function. DNA-fragmentation testing may be considered in selected pathways such as unexplained infertility, recurrent pregnancy loss, or repeated assisted-reproduction failure, depending on the guideline and specialist judgment. It is not a universal first test.

Different assays and thresholds complicate interpretation, and an abnormal result does not point automatically to one treatment. NICE 2026 advises against offering supplements, antioxidants, or medical treatments specifically to improve sperm DNA integrity because evidence for meaningful outcomes is insufficient.

Oxidative-stress panels, antisperm antibodies, sperm-selection add-ons, and broad microbiome tests should answer a defined clinical question. A clinic should explain whether the result changes a treatment with proven benefit.

Treatment follows the cause and both partners’ context

A defined hormone deficiency due to reduced pituitary stimulation may be treated with specialist hormone therapy. Androgens are not used to treat semen abnormalities because they can suppress sperm. Antibiotics are used for an identified infection, not for white cells alone in the hope of improving pregnancy rates.

Selected clinically detected varicoceles with reduced semen parameters may be treated surgically or radiologically after considering spontaneous-conception plans and the other partner’s fertility. Obstruction may be reconstructed or sperm may be retrieved. In non-obstructive azoospermia, specialist retrieval can sometimes find sperm, but success is not guaranteed.

Depending on total motile sperm, female or egg-source factors, age, and duration, options may include timed intercourse, intrauterine insemination, IVF, or injection of a single sperm into an egg. ICSI can overcome some fertilization barriers but does not correct genetic risk or guarantee embryo development, pregnancy, or live birth.

Fertility preservation

Sperm freezing should be discussed before chemotherapy, pelvic radiation, testicular surgery, or other gonadotoxic treatment whenever feasible. People planning gender-affirming hormones or procedures can also request preservation counseling. An urgent cancer treatment should not be delayed without agreement from the oncology team.

If ejaculation is not possible or no sperm are present in semen, specialist retrieval or tissue preservation may be considered in selected cases. Storage consent, future use, cost, duration, and legal rules differ by country.

Supplements and “sperm boosting” claims

No supplement can be selected from a semen value alone. Antioxidants are heavily marketed, but current NICE guidance does not recommend supplements to treat impaired semen parameters or DNA integrity outside research. Products may contain excessive nutrients, undeclared hormones, or ingredients that interact with medicines.

A nutritious diet, appropriate activity, sleep, smoking cessation, reduced harmful alcohol or drug use, and avoidance of anabolic steroids support general health. They should not become a promise that count or morphology will normalize.

Questions people often ask

Does a low sperm count mean pregnancy is impossible?

No. It reduces probability in context, but severity, movement, other parameters, partner factors, and treatment options matter.

Can morphology alone diagnose infertility?

No. Strict morphology is one variable with measurement variation and must be interpreted with total sperm number, motility, history, and the couple’s full fertility picture.

Can testosterone improve sperm?

External testosterone usually suppresses sperm production and should not be used as a fertility supplement. Specialist hormone therapy is different and is reserved for defined disorders.

Does azoospermia mean there are no options?

No. It must be confirmed and classified as obstructive or non-obstructive. Reconstruction, sperm retrieval, donor sperm, or other family-building routes may be discussed, but outcomes vary.

Sources and evidence scope

This guide was researched using the WHO 2025 infertility guideline, NICE guideline NG257 (2026), the European Association of Urology 2026 guideline, the AUA/ASRM male infertility guideline, the WHO semen laboratory manual, and the CDC infertility FAQ. Evidence and guidance were checked on August 21, 2026. Laboratory methods, reference reporting, genetic criteria, treatment access, storage law, and emergency numbers vary by country.